Glutamate, the major excitatory amino acid (EAA) in the CNS has been implicated in neuronal injury associated with cerebral &hernia, epilepsy, and chronic neurodegenerative disorders (Meldrum and Garthwaite, 1990) . Glutamate receptors have been classified as either ionotropic or metabotropic (Meldrum and Garthwaite, 1990) . The recent molecular cloning of the subunits for the ionotropic glutamate receptors has confirmed the original classification of AMPA, kainate and NMDA receptors. These receptors are composed of homo-or heteromeric combinations of subunits for AMPA/kainate receptors, GluR5-7 and KAI -2 for kainate receptors, and NMDARI and NMDAR2A-D for NMDA receptor) (Nakanishi, 1992; Seeburg, 1993) . Activation of the NMDA subtype of the glutamate receptor has been shown to be the major contributor to cell death in cortical cell cultures subjected to acute excitotoxicity or oxygen and glucose deprivation (Choi, 1987 (Choi, , 1988 Goldberg and Choi, 1993; Hartley et al., 1993) . The early biochemical feature of NMDA-induced excitotoxicity in neurons is the disturbance in ionic balance triggered by calcium and sodium influx through the NMDA receptor/channel complex (Choi, 1987 (Choi, , 1988 Marcoux et al., 1990; Goldberg and Choi, 1993; Hartley et al., 1993; Weber et al., 1993) . One consequence of such ionic imbalance is the activation/overactivation of many vital cellular enzymes (protein kinases and phosphatases, phospholipases and proteases), in particular those regulated by calcium followed by a cascade of both biochemical and physical changes (cytoskeletal breakdown) leading to neuronal death (Siman and Noszek, 1988; Saido et al., 1994) .
One such enzyme, CamK-II, has an important role in decoding signals generated by neurotransmitters which raise intracellular free calcium ([Caz+],). CamK-II is highly enriched in neurons, both in the pre-and postsynaptic compartments where it is essential to neurotransmitter release and induction of LTP, respectively (Llinas et al., 198.5; Malenka et al., 1989; Greengard, 1993) . Recent studies have also linked CamK-II to regulation of both voltage-gated and ligand-gated ion channels, in particular those associated with glutaminergic neurotransmission (Greengard et al., 199 1; Wang et al., 199 I ; Keller et al., 1992; Raymond et al., 1993; McGlade-McCulloh et al., 1993) . CamK-II is a serine-threonine kinase activated by an increase in [Ca?'] , (bound to calmodulin) following an appropriate agonist stimulation, such as NMDA (Fukunaga et al., 1990 . Once activated by the Ca*+/calmodulin, 20-80s of the enzyme activity is maintained by its conversion to a Ca*'-independent form via autophosphorylation.
This posttranslational modification of CamK-II is a rapid process in neurons and could be a key factor in its sustained catalytic activity (Rich et al., 1990; Yamamoto et al., 1992) .
The main feature of this multifunctional kinase is phosphorylation of a number of substrate proteins, which mediate many of the actions of cellular second messengers. Several investigators have shown that phosphorylation of the AMPA/kainate receptor by protein kinases such as CamK-II, protein kinase C (PKC) or CAMP-dependent protein kinase (PKA) regulates its function in neurons (Greengard et al., 1991; Wang et al., 1991; Keller et al., 1992; McGlade-McCulloh et al., 1993; Raymond et al., 1993) . The NMDA subtype of glutamate receptor is also modulated by phosphorylation in neurons (Chen et al., 1992; Kitamura et al., 1993) . In all cases, glutamate receptor phosphorylation leads to a positive modulation on the receptor function maintaining synaptic excitability. The importance of CamK-II in maintenance of synaptic excitability and also its extreme vulnerability in in viva models of ischemia (Churn et al., 1992; Hanson et al., 1994) and in vitro excitotoxicity (Churn et al., 1993) have led us to examine its potential contribution in EAAmediated cell death.
Therefore, to examine the role of CamK-II in EAA-mediated neurotoxicity in fetal rat cerebrocortical cultures, we used the CamK-II specific inhibitor KN-62 with proven cell permeability (Tokumitsu et al., 1990; Hidaka and Hagiwara, 1992) . KN-62 competitively inhibits CamK-II with respect to calcium/calmodulin and has no inhibitory effect on PKA, PKC, myosin light chain kinase, or casein kinase-I (Tokumitsu et al., 1990; Hidaka and Hagiwara, 1992) . KN-62 is not a calmodulin antagonist and is only effective on inhibiting the activity of CamK-II before its autophosphorylation.
KN-62 has also been used previously as a specific inhibitor for CamK-II in various neuronal systems (Figurov et al., 1993; Hack et al., 1993 in their 18th day of gestation and were trypsin digested and triturated into single cell suspension. cells were pipetted into individual wells of poly-L-lysine-coated plates, yielding a final cell concentration of 200,000 cells/cm' using GIBCO Minimum Essential Medium (MEM; containing 10% horse and 10% fetal bovine serum; heat inactivated). Non-neuronal cell division was halted three days into culture by adding 25 kg/ml uridine and 10 kg/ml 5-fluoro-2'-deoxyuridine. Feeding were performed as necessary with MEM with 10% horse serum. Experiments were performed on 17-21 d (postisolation) old neurons. Cultures were triple washed with MEM (serum free) with or without the test agents (inhibitors). NMDA was added directly to the culture media. After 30 min incubation at 37"C, NMDA was washed by triple exchange with serum free MEM (+inhibitors).
Final concentration of glucose in the MEM throughout the culture period was 30 rnM.
Cell viability assay. Neuronal injury was assessed qualitatively by light microscopic examination of the phase contrast appearance of cultures. Quantitative assessments of neuronal injury were made using lactate dehydrogenase (LDH) release as a marker for membrane breakage and cell death (Koh and Choi, 1987) . One day post experiment initiation, 2.5 l.~l of culture medium was combined with 225 p,l of 0.1 mM potassium phosphate buffer containing 0.133 mg/ml P-NADH. Following a 20 min incubation at 37"C, wells received 30 p,l of sodium pyruvate (2.39 mM in phosphate buffer, pH 7.5) and kinetic measurements (at 340 nm for 2 min) were immediately performed using a Titertek Multiscan plate reader.
Calcium microspectrojuorimetry. Experiments were performed using a PTI Deltascan system (Princeton, NJ). Neurons were loaded with 2-4 FM FURA-AM (Molecular Probes, Eugene OR) in buffer (in mM: NaCl, 137; KCl, 2.6; Na,PO,, 8.1; MgCl,, 0.5; CaCl,, 0.9; HEPESNaOH, 10; glucose, 11; with 150 mg/ml bovine serum albumin, pH = 7.4) at room temperature for 1 hr and rinsed in the same buffer without FURA-AM but with added glycine (10 PM) for at least 15 min. A single cell was observed (40X objective, n.a. 1.3) and alternatively illuminated at 340 and 380 nM. Photometric measurements at 510 nM were made continuously at a rate of 5 Hz. Drugs were bath applied by superfusion (1 ml/min). Tetrodotoxin (300 nM) was added in the superfusion media to reduce spontaneous calcium oscillations. Results were quantified by measuring the area under the curve of the fluorescence ratio (F,,,IF,,,) versus time waveform; for each cell the second 1 min challenge with 25 JLM NMDA was used to normalize the results. Each neuron was challenged three times with 25 )LM NMDA (1 min), and waveforms from the second and third challenges were used for area quantification.
Recepfor binding assay. Well-washed rat brain membranes from a lysed buffy coat fraction were prepared according to the method of Kishimoto et al (198 1 400 pg) were incubated with 'H-glutamate (2 nM) and JH-glycine (20 nM) for 30 min on ice. Specific binding for ?H-glutamate (80%) was defined as that displaced in the presence of 0.1 mM NMDA and for ?Hglycine (65%) as that displaced by 0.1 mM 5,7-dichlorokynurenic acid. 'H-TCP (2 nM) binding was carried out as described above except the incubations were for 1 hr at room temperature in 20 mM HEPES-KOH buffer (pH 7.4). 'H-AMPA (10 nM) and 'H-kainate (20 nM) binding was carried out in a 50 mM Tris-HCl buffer (pH 7.4) containing either IO mM potassium thiocyanate for 'H-AMPA or 20 mM CaCI, for 'H-kainate for 1 hr on ice. Specific binding was defined as that displayed in the D Control NMDA presence of 1 mM glutamate. Filtration was done with a Brandell MBeither placed back in the normoxic conditions until 24 hr postexperi-48R cell harvester through Whatman GF/B filters. Radioactivity was ment initiation for LDH measurement or used immediately for a5Ca*+ quantified by liquid scintillation counting. determinations. Electrophoresis und Western blotting. Proteins were analyzed by SDS-PAGE according to the method of Laemmli (1970) . After electrophoresis, proteins were blotted onto PVDF membrane (Towbin et al., 1979) and blocked with 5% nonfat milk. Blots were incubated overnight in primary antisera and then one hour with biotinylated secondary antiserum. The immunoreactivity was visualized by alkaline phosphataseconjugated streptavidin (Amersham). Anti-spectrin (cu-fodrin; monoclonal) was purchased from Affiniti Laboratories, U.K.
Results and Discussion
rrCaz+ accumulation studies. These were carried out according to the method of Birrell et al. (1993) . Briefly, cells were washed three times with Mg?+-free HBSS containing 2.5 mM Ca'+, and incubated with the test drugs for one hour. 45CaZ+ (2 l&i/ml) was present 20 min prior to, during NMDA exoosure (30 min at 37°C). Ceils were washed three times-with saline and lysed with distilled water, and 45Ca2+ B emissions in the intracellular contents were counted by scintillation spectroscopy.
NMDA receptors appear to participate in the process of excitotoxicity and neuronal death. The hallmark of NMDA-induced neuronal death is a sustained increase in the [Ca*+], and overactivation of vital Ca2+-dependent cellular enzymes such as calpain and CamK-II.
Calpain overactivation with the presence of high [Ca*+], following NMDA receptor (NMDAR) overstimulation leads to breakdown of structural proteins (e.g., spectrin) and proteolysis of other cellular substrates (Siman and Noszek, 1988; Saido et al., 1994) . Specific inhibitors of calpain have proved to be neuroprotectant in EAA-induced neurotoxicity (for review, see Saido et al., 1994; Wang and Yuen, 1994 Oxygen/glucose (hypoxia/hypoglycemiu) deprivation studies. Cerebrocortical cells were plated onto 96-well, PEI coated culture plates using DME/Fl2 medium containing 10% horse and 6% fetal bovine serum (heat inactivated). Non-neuronal cell division was halted 3 d into culture by adding 25 kg/ml uridine and 10 kg/ml 5-fluoro-2'-deoxyuridine. Oxygen/glucose deprivation in cultures were carried out according to Weber et al. (1993) . Briefly, culture growth media was removed and replaced with defined media and then cultures were deprived of oxygen and glucose for O-330 min (exposure atmosphere: in triple gas incubator, I% O?, 8% CO,, 91% Nz; for exposure medium, 1. measured the activity of the cytoplasmic enzyme, lactate dehydrogenase (LDH) released in the media (Koh and Choi, 1987) ; immunodetection of proteolytic fragments (I 50 and 145 kDa) of the cytoskeletal protein cr-fodrin (spectrin; 240 kDa) as produced by calpain (Siman and Noszek, 1988) , and morphology by light microscopy.
Previous work by others have shown a good correlation between neuronal death (by dye-exclusion method) and LDH measurements (Koh and Choi, 1987; Goldberg et al., 1987) . Pretreatment (I hr) with KN-62 (5 PM) offered a significant reduction (65%) in LDH release, 24 hr following application of 125 and 250 FM NMDA (30 min at 37°C) (Fig. 1A) . Neuroprotection achieved by KN-62 was robust when, administered 1 hr before NMDA application and included throughout the postincubation period (24 hr). However, we observed a significant but marginal protection (reduction in LDH release) against NMDA toxicity with KN-62 pretreatment only; neither simultaneous administration with NMDA nor post-NMDA application only of KN-62 was neuroprotective (Fig. 1B) . In comparison, competitive NMDA receptor antagonist 3-[( + )-2-carboxypiperazine-4-yllpropyl-1 -phosphonic acid (CPP) at 100 FM was highly neuroprotective in all treatment paradigms as expected (Fig. IB) . Furthermore, both biochemical (LDH activity and spectrin immunoblot) and morphological data show preservation of neurons by when acutely treated with NMDA (Fig. l&D) (Fig. 2) . This is in agreement with previous reports using KN-62 in cell-based systems (Tokumitsu et al., 1990; Hidaka and Hagiwara, 1992; Hack et al., 1993; Figurov et al., 1993) . Effective concentrations of KN-62 (0.5-10 PM) against NMDA-induced toxicity observed in this study have been shown to provide 75-80% inhibition of CamK-II activity in the exogenous substrate phosphorylation (Tokumitsu et al., 1990) .
The effect of KN-62 appears to be selective since, calmidazolium (a calmodulin antagonist), genistein (a tyrosine protein kinase inhibitor), K252a (a nonspecific protein kinase inhibitor) and calphostin C (a PKC inhibitor) were not neuroprotective against 125 and 250 PM NMDA challenge (Table 1) . Calmidazolium and calphostin C, at concentrations used here and mode of application (pre/co/post), exacerbated NMDA-induced toxicity (Table 1) . However, compound 5 (a mixed tyrosine kinase and CamK-II inhibitor) produced a significant protection against both doses of NMDA tested (Table 1 ). The lower degree of protection observed by compound 5 could be due to its lack of binding specificity to CamK-II as compared to KN-62. It would be ideal to have highly specific inhibitors like KN-62 (which does not compete with ATP) for the major classes of protein kinases (e.g., PKA and PKG) to test in such excitotoxicity paradigms. The availability of such compounds will allow one to determine the components involved, and also test combination strategies, in this model of neuronal death.
To complement these studies, the ability of KN-62 to protect neurons in an oxygen/glucose-deprivation (hypoxia/hypoglycemia) induced neurotoxicity model in rat cortical cultures was examined.
This in vitro model of neurotoxicity has previously been shown to be primarily mediated through the NMDA receptor and can be blocked effectively by NMDA antagonists (Choi, 1987 (Choi, , 1988 Marcoux et al., 1990; Goldberg and Choi, 1993; Hartley et al., 1993; Weber et al., 1993) . Neuronal degeneration in this type of insult is similar to those associated with partial focal cerebral ischemia in viva (e.g., middle cerebral artery occlusion in rat). Oxygen/glucose deprivation interval of
The Journal of Neuroscience, May 1995, f5 (5) deprivation-induced (labeled as hypoxia) neuronal death by and CPP (100 PM). A, LDH release with increasing duration of deprivation. Samples were taken 24 hr post experiment initiation.
Data are means f SEM from six observations. All data points from 180-300 min were statistically significant compared to hypoxic control values with at least p 5 0.01 (Student's t test). B, Western blot analysis of proteins extracted from 240 min deprivation interval, probed with antispectrin antibody. molecular weight markers (kDa) are shown on the left. Solid arrow shows intact spectrin (240 kDa) and open arrowheads show proteolytic breakdown fragments of spectrin (150 and 145 kDa). 240 min (4 hr; followed by 24 hr incubation in normoxic conditions) in our cultures produces maximum neuronal degeneration (Fig. 3) . Pretreatment
(1 hr) and continuous presence of KN-62 dose dependently and significantly reduced neurotoxicity in this model, as evaluated by LDH release and calcium accumulation (Figs. 3, 4B) . Immunoblot of proteins (labeled with antispectrin antibody) extracted from 240 min of hypoxia/hypoglycemia condition show reduced proteolytic fragments of intact spectrin in KN-62 pretreated cultures compared to the appropriate control (Fig. 3B) . However, immunoblots of spectrin and its proteolytic fragments, did not reflect the dose-response of KN-62 observed with the LDH release assay in this toxicity paradigm (Fig. 3B) . This may be due to the qualitative rather than quantitative nature of spectrin immunoblots in such a protocol. Neuroprotection seen by KN-62 (at 5 and 10 PM) was effective up to 260 min of oxygen/glucose deprivation followed by 24 hr in normoxic condition. The competitive NMDA antagonist CPP (100 FM) produced almost complete protection against all deprivation intervals, as seen in LDH release (Fig. 3A) and calcium accumulation (Fig. 4B) . One common feature in NMDA or oxygen/glucose deprivation-induced toxicity is an increase in the level of intracellular free calcium ([Ca*+],), which has been shown to correlate well with consequent (delayed) neuronal death (Choi, 1987 (Choi, , 1988 Marcoux et al., 1990; Goldberg and Choi, 1993; Hartley et al., 1993; Weber et al., 1993) . KN-62 reduced calcium (45Ca*+) accumulation by 34-58% in NMDA toxicity and IO-100% in oxygen/glucose deprivation, depending on the degree of the insults (Fig. 4) .
To further investigate the effect of KN-62 on calcium influx, Figure 4 . Calcium accumulation following NMDA challenge or oxygen/ glucose (hypoxia/hypoglycemia) deprivation. A, 'Va*+ uptake after NMDA (60-500 PM) challenge for 30 min in presence or absence of 5 FM (1 hr pretreatment). **, p 5 0.001; *, p I 0.01, Student's t test. B, Wa*+ uptake with increasing duration of oxygen/glucose deprivation. Data are means L SEM of six to eight determinations. All data points from 165-300 min for CPP, and for (Figs. 1, 2) , indicating that such an insult is multifactorial. The subunit of NMDA receptor (NMDARl) essential for forming a functional receptor channel is a 938 amino acid protein with putative phosphorylation sites for PKC in the C-terminal cytosolic region (Ishii et al., 1993) . Upon phosphorylation by PKC calcium current through the NMDA receptor is enhanced by removing the voltage-dependent Mg2+ block (Chen and Huang, 1992) . According to the rat NMDARl sequence by Ishii et al. (1993) , amino acid residues 880-883 (Arg-Ala-IleThr) N-terminal from the PKC phosphorylation domain (902-907), fits the consensus phosphorylation sites for CamK-II (Arg/ Lys-Xxx-Yyy-Ser/Thr) (Schulman and Hanson, 1993 and/or related compounds in in vivo models of neurotoxicity (ischemia/stroke).
The findings in this study provide clear evidence that inhibition of CamK-II can alter the course of NMDA-mediated excitotoxicity and this protein kinase may play a critical role in processes involved with neuronal pathophysiology.
